Kirchhammer et al. Successful IL-12 cancer immunotherapy requires NK cell-derived CCL5 for anti-tumor DC-T cell crosstalk
暂无分享，去创建一个
A. Plückthun | E. Bartoszek | D. Thommen | Marcel P. Trefny | A. Zippelius | H. Läubli | D. Schreiner | P. Zaytseva | M. Schmid | N. Kirchhammer | Abhishek S. Kashyap | M. Buchi | Michal A. Stanczak | D. Brücher | Marina Natoli | Sheena N. Smith | F. Werner | Daniel Breu | K. P. Hartmann | Victoria B Koch | M. Trefny | Victoria B. Koch | K. Hartmann